The words approved in red capitalized letters

Glenmark obtains FDA nod for generic Prolixin

Fluphenazine is a medication that treats mental health conditions that cause disruptive thoughts and nervousness.
Sandra Levy
Senior Editor
Levy

Glenmark has received the Food and Drug Administration’s green light for fluphenazine hydrochloride tablets, 1 mg, 2.5 mg, 5 mg and 10 mg, which is the generic of Apothecon’s Prolixin.

Fluphenazine is a medication that treats mental health conditions that cause disruptive thoughts and nervousness. 

Glenmark's generic Prolixin will be distributed in the United States by Glenmark Pharmaceuticals USA.

[Read more FDA grants Glenmark tentative approval for generic Enstilar]

Prolixin had a market value of approximately $18.1 million for the 12-month period ending September 2023, per IQVIA.

[Read more: Glenmark obtains FDA nod for generic Protopic]

X
This ad will auto-close in 10 seconds